News | November 10, 2023
SMS Pharmaceuticals reports robust Q2FY24 operational performance
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Advances Amgen's mission to serve patients with rare disease medicines
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Good momentum in commercial CDMO business
Subscribe To Our Newsletter & Stay Updated
